BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 15938925)

  • 1. [Application of urinary nucleosides in the diagnosis and surgical monitoring of colorectal cancer].
    Feng B; Zheng MH; Zheng YF; Lu AG; Li JW; Wang ML; Ma JJ; Xu GW; Yu BM
    Zhonghua Wai Ke Za Zhi; 2005 May; 43(9):564-8. PubMed ID: 15938925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normal and modified urinary nucleosides represent novel biomarkers for colorectal cancer diagnosis and surgery monitoring.
    Feng B; Zheng MH; Zheng YF; Lu AG; Li JW; Wang ML; Ma JJ; Xu GW; Liu BY; Zhu ZG
    J Gastroenterol Hepatol; 2005 Dec; 20(12):1913-9. PubMed ID: 16336453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Significance of urinary nucleosides in diagnosis of gastric carcinoma].
    Chen YJ; Zheng YF; Wang NF; Lu S; Pang T; Yang Q; Xu GW
    Ai Zheng; 2003 May; 22(5):537-40. PubMed ID: 12753721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of urinary nucleosides as potential tumor markers in human colorectal cancer by high performance liquid chromatography/electrospray ionization tandem mass spectrometry.
    Hsu WY; Chen WT; Lin WD; Tsai FJ; Tsai Y; Lin CT; Lo WY; Jeng LB; Lai CC
    Clin Chim Acta; 2009 Apr; 402(1-2):31-7. PubMed ID: 19135043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary nucleosides as biological markers for patients with colorectal cancer.
    Zheng YF; Yang J; Zhao XJ; Feng B; Kong HW; Chen YJ; Lv S; Zheng MH; Xu GW
    World J Gastroenterol; 2005 Jul; 11(25):3871-6. PubMed ID: 15991285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of urinary nucleosides as helper tumor markers in hepatocellular carcinoma diagnosis.
    Jeng LB; Lo WY; Hsu WY; Lin WD; Lin CT; Lai CC; Tsai FJ
    Rapid Commun Mass Spectrom; 2009 Jun; 23(11):1543-9. PubMed ID: 19399767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of serum preoperative carcinoemberyonic antigen in colorectal cancer patients.
    El-Awady S; Lithy R; Morshed M; Khafagy W; Abd Monem H; Waleed O; Badr S; Fekry A; El Nakeeb A; Ghazy H; El Yamany M; Metwally T; El-Arman M; Farid M
    Hepatogastroenterology; 2009; 56(90):361-6. PubMed ID: 19579599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of tumor markers in diagnosing and monitoring colorectal cancer and strategies for further improvement: analysis of 130 cases.
    Chen C; Chen LQ; Yang GL; Li Y
    Ai Zheng; 2007 Nov; 26(11):1221-6. PubMed ID: 17991322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
    Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY
    Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liquid chromatography tandem mass spectrometry study of urinary nucleosides as potential cancer markers.
    Struck W; Siluk D; Yumba-Mpanga A; Markuszewski M; Kaliszan R; Markuszewski MJ
    J Chromatogr A; 2013 Mar; 1283():122-31. PubMed ID: 23465127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary modified nucleosides as tumor markers in cancer of the urinary organs or female genital tract.
    Koshida K; Harmenberg J; Stendahl U; Wahren B; Borgström E; Helström L; Andersson L
    Urol Res; 1985; 13(5):213-8. PubMed ID: 4060364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.
    Takagawa R; Fujii S; Ohta M; Nagano Y; Kunisaki C; Yamagishi S; Osada S; Ichikawa Y; Shimada H
    Ann Surg Oncol; 2008 Dec; 15(12):3433-9. PubMed ID: 18846401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Excretion pattern investigation of urinary normal and modified nucleosides of breast cancer patients by RP-HPLC and factor analysis method.
    Xu G; Schmid HR; Lu X; Liebich HM; Lu P
    Biomed Chromatogr; 2000 Nov; 14(7):459-63. PubMed ID: 11113924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum p53 antibody as tumor marker for follow-up of colorectal cancer after curative resection.
    Tang R; Yeh CY; Wang JY; Changchien CR; Chen JS; Hsieh LL
    Ann Surg Oncol; 2009 Sep; 16(9):2516-23. PubMed ID: 19565285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic accuracy of serum-carcinoembryonic antigen in recurrent colorectal cancer: a receiver operating characteristic curve analysis.
    Körner H; Söreide K; Stokkeland PJ; Söreide JA
    Ann Surg Oncol; 2007 Feb; 14(2):417-23. PubMed ID: 17103264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial growth factors C and D represent novel prognostic markers in colorectal carcinoma using quantitative image analysis.
    Hu WG; Li JW; Feng B; Beveridge M; Yue F; Lu AG; Ma JJ; Wang ML; Guo Y; Jin XL; Zheng MH
    Eur Surg Res; 2007; 39(4):229-38. PubMed ID: 17446709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioinformatical evaluation of modified nucleosides as biomedical markers in diagnosis of breast cancer.
    Bullinger D; Fröhlich H; Klaus F; Neubauer H; Frickenschmidt A; Henneges C; Zell A; Laufer S; Gleiter CH; Liebich H; Kammerer B
    Anal Chim Acta; 2008 Jun; 618(1):29-34. PubMed ID: 18501242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gas chromatography/mass spectrometric analysis of urinary nucleosides in cancer patients; potential of modified nucleosides as tumour markers.
    Langridge JI; McClure TD; el-Shakawi S; Fielding A; Schram KH; Newton RP
    Rapid Commun Mass Spectrom; 1993 Jun; 7(6):427-34. PubMed ID: 8329765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Separation and identification of purine nucleosides in the urine of patients with malignant cancer by reverse phase liquid chromatography/electrospray tandem mass spectrometry.
    Li HY; Wang SM; Liu HM; Bu SS; Li J; Han D; Zhang MZ; Wu GY
    J Mass Spectrom; 2009 May; 44(5):641-51. PubMed ID: 19142897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Cystatin SN as a novel tumor marker for colorectal cancer.
    Yoneda K; Iida H; Endo H; Hosono K; Akiyama T; Takahashi H; Inamori M; Abe Y; Yoneda M; Fujita K; Kato S; Nozaki Y; Ichikawa Y; Uozaki H; Fukayama M; Shimamura T; Kodama T; Aburatani H; Miyazawa C; Ishii K; Hosomi N; Sagara M; Takahashi M; Ike H; Saito H; Kusakabe A; Nakajima A
    Int J Oncol; 2009 Jul; 35(1):33-40. PubMed ID: 19513549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.